High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma - Wikidata - wikimedia - TriplyDB

High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma

High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma

http://www.wikidata.org/entity/Q34314010

about

Gastric biomarkers: a global review Molecular alterations in gastric cancer with special reference to the early-onset subtype Companion diagnostics for the targeted therapy of gastric cancer Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families Comprehensive molecular characterization of gastric adenocarcinoma PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.Distribution of somatic mutations of cancer-related genes according to microsatellite instability status in Korean gastric cancer.Pathogenetic mechanisms in gastric cancer.Genetics of familial melanoma: 20 years after CDKN2A.High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated Causes and consequences of microsatellite instability in gastric carcinogenesis.Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer.Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with β-catenin and correlation with poor prognosis Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer.Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.Gastric Cancer Genomics: Advances and Future Directions.Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?Innovative personalized medicine in gastric cancer: time to move forward.The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer.Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53.Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing.Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients; Utility of Targeted Deep Sequencing for Biomarker-Selected Clinical Trial.Clinical significance of circulating plasma DNA in gastric cancer.Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women.FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer.Biomarkers of gastric cancer: Current topics and future perspective

P2860

Q26741859-05BEF970-0D8E-42BE-883E-D205E0CB13AE Q26764919-EF4B7088-58F8-4021-B7EE-7AEEF9E832D1 Q26780298-9332103E-0D51-40BE-9D40-433ED28598F8 Q27024034-C916DA86-AD7B-4878-9052-B075CBFCE58B Q28086989-808BBDFA-6F05-48BA-9591-076850BC328F Q28242124-0DF59FF0-2DA4-4B8C-BE8E-264F2099A22E Q28244985-A5333ECF-4E77-4BB4-A345-FD28E2D52FFB Q28247338-AEDF5B83-EAA0-4995-8D26-7D05F3DB5654 Q33768759-FC3D56D8-42F8-4F66-A8BB-448EDD3450C0 Q33833750-9FF5A91B-F124-4B5D-B5F6-A30BD9D7B7BD Q34326627-D985169E-7D2B-430C-838F-12FD6C4E87F6 Q34449957-68920E3D-B4F4-4DF4-80A4-B32BF8604C55 Q34456612-29FBCCC5-900A-47E5-B68F-81089E9B1A53 Q34541232-A5CEDD06-1694-4213-890B-6A365F0BDC4F Q34589660-45758C58-86A6-4AB4-AB5D-6CFBE9ABEC93 Q35076221-9474DFFA-513C-48F5-B556-74035F93A70B Q35664233-F5A28F35-CFFF-45F6-A351-5DE24A323342 Q36383885-A0A906D8-DA2C-468B-A743-BD1222EAFE90 Q36413660-7BB66903-73C5-4855-ACC9-577D135716A4 Q36905878-8455D94C-0F90-43C2-8B72-E207533DFFE5 Q37673604-8BF5B47B-8DC7-47A1-A91B-B166BA0EBED8 Q38184380-5EA9DB63-D353-42B6-897D-16A1B0C68E3F Q38205887-CCC27061-0E77-454F-B738-A096C1C0B772 Q38297145-E4E11565-7727-43E8-9834-83EF8D81398E Q38527414-4D398D91-384B-49A1-937E-458FCB4FC4E4 Q38585708-13B54856-BE16-4378-B06E-B8816285C456 Q39089973-6ABD6F7A-8AA1-4FD2-A03F-3EDF15F0BC62 Q39096557-105CECBA-9C22-4306-B0F6-BDB8C467BAD1 Q40125226-79017520-29F1-417F-8C78-02778CE5414E Q40948643-00742D51-704A-4D32-ACBE-AC24F423A9FD Q41519401-FCC37CFC-8340-42D1-9C76-03E2A3456DDE Q43115752-07130925-89C2-456A-9FF3-694A1FF7F234 Q48379063-AB34D74C-655F-4D1B-9A7A-333F539AB667 Q54542254-F908C3C0-7085-4FB8-A0DF-EC7D11BBD08B Q54951367-A1EDADBD-3A24-4C72-84F9-84EC4B1BCB45 Q57176090-1720D937-DD6C-47A9-A3AD-8F972BFA41E4

P2860

High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma

http://www.wikidata.org/entity/Q34314010

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@ast

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@en

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@nl

type

label

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@ast

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@en

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@nl

prefLabel

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@ast

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@en

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@nl

P1433

Q34314010-F318FB91-2C28-4198-BE4C-2675AFC5F02B

P1476

Q34314010-0E97E8C9-E7A0-4038-8C5C-A6C795379CE5

P2093

Q34314010-24C6CCD6-67AA-4057-AAFF-4AEB5209DA88

Q34314010-29083A09-3232-4A49-9037-17D76055CE71

Q34314010-7750AF35-5F2D-4225-9700-C68103A682F3

Q34314010-86EEC3C5-7EBB-4C9D-B8C1-FE740452B4EA

Q34314010-9276C632-F927-4677-BD23-D23F60323E1F

Q34314010-998E3F6A-E144-4053-A903-9D4203977D1F

Q34314010-CBF1BBB3-8B9A-443E-B4F8-2BEA5760BD69

Q34314010-CC548DA8-103D-472C-A8DD-F1F0DA50838C

Q34314010-DE026EC9-9906-47B6-B65C-EC872DECDAD6

Q34314010-F55625DB-20FB-41FE-9B71-15AEE37FC614

P2860

Q34314010-0EC1DBE1-B5E2-45FA-BAF9-1876D3275D62

Q34314010-12961C7B-2B47-43A9-9FB6-DAAB109CF13A

Q34314010-26B3D74A-3C34-4213-97DC-838E959FF041

Q34314010-29A99FC3-AE52-4F98-8F31-A4EE73C31112

Q34314010-29C97726-F010-41C5-84D5-1C89D309C81F

Q34314010-316A93A2-016B-4B4B-8057-D97BD293E1B4

Q34314010-3EE06217-0F7C-46D6-A05B-FDF6C44F73CC

Q34314010-4F3B4B5E-B442-492E-B628-CDB7517C7389

Q34314010-68B8E55C-533D-45CF-99ED-4E4C53FB8E98

Q34314010-7996730D-A052-481D-938C-CC077C3FF698

P304

Q34314010-85BE044E-B7C3-4872-B813-BBADC975C466

P31

Q34314010-43D8CFC9-C51E-45D6-B423-F6DD99F2D0AE

P356

Q34314010-80E15AFE-4FF4-4696-9DA0-00FD60F7878E

P407

Q34314010-F7070EBD-3D43-490C-9186-514549D39DAE

P433

Q34314010-F6BAC3DD-5516-4070-B2CB-19EFEFA1778A

P478

Q34314010-5307000C-36F1-44C5-9274-DD699904D956

P50

Q34314010-4D9F11D1-3546-460B-BD84-7434FDCF579C

P577

Q34314010-7B7EAE00-7E9A-4B87-9BF5-6C4E7C2FAA2F

P5875

Q34314010-BFFD134E-799A-4B2D-AE90-2186884B2053

P698

Q34314010-D1450AFD-7FD4-4E1B-85BF-1A80333FBE96

P921

Q34314010-76B77675-2001-486A-AC2F-6A03870EA0E6

P932

Q34314010-074E4023-46C9-41D9-8C2F-F6932B2E73D3

P356

JOURNAL.PONE.0038892

P1433

P1476

High-throughput mutation profi ...... dvanced gastric adenocarcinoma

@en

P2093

Emanuele Palescandolo

http://www.w3.org/2001/XMLSchema#string

Ha Young Park

http://www.w3.org/2001/XMLSchema#string

Jeeyun Lee

http://www.w3.org/2001/XMLSchema#string

Jiryeon Jang

http://www.w3.org/2001/XMLSchema#string

Joon Oh Park

http://www.w3.org/2001/XMLSchema#string

Kyoung-Mee Kim

http://www.w3.org/2001/XMLSchema#string

Laura MacConaill

http://www.w3.org/2001/XMLSchema#string

Paul van Hummelen

http://www.w3.org/2001/XMLSchema#string

So Young Kang

http://www.w3.org/2001/XMLSchema#string

Won Ki Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of PIK3CA in gastric adenocarcinoma

Profiling critical cancer gene mutations in clinical tumor samples

Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

p53, the cellular gatekeeper for growth and division

High frequency of mutations of the PIK3CA gene in human cancers

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

Oncogenic mutations of PIK3CA in human cancers

High throughput interrogation of somatic mutations in high grade serous cancer of the ovary

P304

e38892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0038892

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227858325

http://www.w3.org/2001/XMLSchema#string

P698

22723903

http://www.w3.org/2001/XMLSchema#string

P921

P932

3377730

http://www.w3.org/2001/XMLSchema#string